Clinical Trials Manager ©

Contact webmaster   Updated 07/02/2009 17:40:31 Trial status: Active Trials found: 420 Clinical Trials Network : Therapeutic group Cardiovascular IM/Other Liver Disease Department Division Anesthesiology Other Dermatology Cosmetic Dermatology Dermatology Clinic General Practice Pediatrics Medicine Cardiology Circulatory Physiology Digestive & Liver Diseases Endocrinology General Medicine Hematology and Oncology Infectious Diseases Medical Oncology Naomi Berrie Diabetes Center Nephrology Preventive Medicine & Nutrition Pulmonary Cardiology Pulmonary, Allergy & Critical Care Medicine Rheumatology Neurological Surgery Epilepsy Movement Neuro Surgeon Neurooncology Spine Neurology Dementia and Aging Epilepsy G H Sergievsky Center General Neurology Movement Disorders Movement Disorders/neuromuscular Multiple Sclerosis and Demyelinating Diseases Neuromuscular Disease Neurooncology Stroke and Critical Care Obstetrics and Gynecology Family Planning & Preventive Services Gynecologic Oncology Maternal Fetal Medicine Menopause Obstetrics and Gynecology Reproduction and Endocrinology Ophthalmology Glaucoma Macula Surgical & Medical Retinal Disease Ophthalmology Other Orthopedic Surgery Lower Extremity and Reconstruction Otolaryngology/head and Neck Surgery Head & Neck Surgery Pathology Hemopathology Pediatrics Autoimmune & Molecular Diseases Cardiology Endocrinology Gastroenterology & Nutrition Hematology and Blood and Marrow Transplant Infectious Diseases Neonatology & Perinatal Medicine Oncology Pulmonary Rheumatology Psychiatry Behavioral Medicine Child Psychiatry Geriatrics Neuroscience Neuroscience - Neuropathology Other Substance Abuse Radiation Oncology Radiation Oncology Radiology Interventional Radiology Neurosurgery School Of Dental and Oral Surgury Periodontics Surgery Allen General Surgery Cardiothoracic Surgery Center For Liver Disease & Transplantation Surgical Oncology Surgical Specialties Vascular Surgery Urology Oncology Trial details Clinical Trials Network Group : Cardiovascular ACCOMPLISH - Prospective, multinational, multicenter, double-blind, randomized, active-controlled, trial to compare effects of Lotrel to benazepril & hydrochlorothiazide combined on reduction of cardiovascular morbidity & morality patients w/ high risk hy   Principal Investigator: Mathew Maurer   Start date: 03/24/2004 End date: 12/24/2009 to request information from Principal Investigator.    Top of page ACCORD - N01 HC 95184/Action to Control Cardiovascular Risk in Diabetes   Principal Investigator: J. Thomas Bigger, Jr.   Website: www.accord-ne.org Start date: 09/30/1999 End date: 04/30/2010 to request information from Principal Investigator.    Top of page ACCORD-Eye - Action to Control Cardiovascular Risk in Diabetes -- Eye Substudy   Principal Investigator: J. Thomas Bigger, Jr.   Website: www.accord-ne.org Start date: 11/01/2003 End date: 04/30/2010 to request information from Principal Investigator.    Top of page RO4607381 - Phase III, double-blind, randomized placebo-controlled study, to evaluate the effects of RO4607381 on cardiovascular (CV) risk in stable CHD patients, with a documented recent Acute Coronary Syndrome (ACS).   Principal Investigator: J. Thomas Bigger, Jr.   Start date: 12/15/2008 End date: 06/30/2011 to request information from Principal Investigator.    Top of page Clinical Trials Network Group : IM/Other ITNTWK - Proleukin and Rapamune in Recent-onset Type 1 Diabetes Mellitus: Phase 1   Principal Investigator: Robin S. Goland (CTN)   Start date: 10/15/2008 End date: 09/14/2011 to request information from Principal Investigator.    Top of page Clinical Trials Network Group : Liver Disease ENTECAVIR-INCOMPLETE - FUNDED ACCOUNT: Protocol No. AI463-026-045 A Phase III Study of the Comparison of Entecavir to Lamivudine in Chronic Hepatitis B Subjects with Incomplete Response to Current Lamivudine Therapy   Principal Investigator: Robert S. Brown   Start date: 04/16/2002 End date: 02/02/2010 to request information from Principal Investigator.    Top of page Department : Anesthesiology Division : Other Fixed dose of sucutaneous methylnaltrexone in adults with advanced illness and opioid induced constipation.   Principal Investigator: Michael Weinberger   Start date: 05/28/2008 End date: 11/30/2013 to request information from Principal Investigator.    Top of page Department : Dermatology Division : Cosmetic Dermatology Early Diagnosis of Melanoma - Early Diagnosis of Melanoma Using Expression Profiling and Non-Invasive Sampling of Skin Cells.   Principal Investigator: Julide T Celebi   Start date: 04/10/2008 End date: 10/31/2009 to request information from Principal Investigator.    Top of page Department : Dermatology Division : Dermatology Clinic **STUDY MGR**A Phase II Pivotal Trial to Evaluate the Safety and Efficacy of Nitrogen Mustard (NM) 0.02% Ointment Formulations in Patients with Stage I or IIA Mycosis Fungoides (MF)   Principal Investigator: Elizabeth Knobler   Start date: 06/12/2007 End date: 12/31/2009 to request information from Principal Investigator.    Top of page Nitrogen Mustard 0.04% - Open Label Six Month Study to Evaluate the Safety and Efficacy of Nitrogen Mustard (NM) 0.04% Ointment Formulation in Patients with Stage I or IIA Mycosis Fungoides (MF) Who Have Completed an Initial 12 Month Treatment with Nitrog   Principal Investigator: Elizabeth Knobler   Start date: 02/14/2008 End date: 09/30/2009 to request information from Principal Investigator.    Top of page Department : Dermatology Division : General Practice **STUDY MGR** An Un-blinded Exploratory Study to Evaluate a Cutaneous Incisional Wound Model of Mast Cell Infiltration in Healthy Volunteers and Idiopathic Pulmonary Fibrosis (IPF) Patients   Principal Investigator: Julian Mackay-Wiggan   Start date: 12/13/2007 End date: 06/30/2010 to request information from Principal Investigator.    Top of page ABT-874 in Psoriasis - Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects with Moderate to Severe Chronic Plaque Psoriasis   Principal Investigator: Julian Mackay-Wiggan   Start date: 02/29/2008 End date: 08/31/2009 to request information from Principal Investigator.    Top of page M03-658 - Multicenter, Open-Label, Continuation Study in Moderate to Severe Chronic plaque Psoriasis Subjects who Completed a Preceding Psoriasis Clinical Study with Adalimumab   Principal Investigator: Julian Mackay-Wiggan   Website: smills@parabio.com Start date: 09/14/2005 End date: 09/06/2009 to request information from Principal Investigator.    Top of page Observational Post-marketing Safety Surveillance Registry of Enbrel (etanercept) for Treatment of Psoriasis   Principal Investigator: Julian Mackay-Wiggan   Start date: 07/20/2006 End date: 02/28/2016 to request information from Principal Investigator.    Top of page Phase 3, multicenter, open-label continuation study in moderate to severe chronic plaque psoriasis subjects who completed a preceding psoriasis study with AB-874   Principal Investigator: Julian Mackay-Wiggan   Start date: 07/08/2008 End date: 08/31/2009 to request information from Principal Investigator.    Top of page Phase III Randomized, Evaluator-Blind, Parallel Group Study of the Safety and Efficacy of Itraconazole Tablets, Itraconazole Capsules and Placebo in the Treatment of Onychomycosis of the Toenail   Principal Investigator: Julian Mackay-Wiggan   Start date: 05/11/2007 End date: 11/30/2010 to request information from Principal Investigator.    Top of page Department : Dermatology Division : Pediatrics APPLES - Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis   Principal Investigator: Kimberly D. Morel   Start date: 11/22/2005 End date: 09/30/2020 to request information from Principal Investigator.    Top of page Prospective, Multicenter, within Subject Controlled Study to Evaluate the Effect of Apligraf in Nonhealing Wounds of Subjects with Junctional or Dystrophic Epidermolysis Bullosa   Principal Investigator: Kimberly D. Morel   Start date: 05/11/2008 End date: 09/30/2009 to request information from Principal Investigator.    Top of page Department : Medicine Division : Cardiology **STUDY MGR*A Rdmzd, OL Study to Compare the Safety and Efficacy of Conversion From A Calcineurin Inhibitor to Sirolimus Verus Continued Use of a Calcineurin Inhibitor in Cardiac Transplant Rcpnts w/Mild to Moderate Renal Insufficiency   Principal Investigator: Donna Mancini   Start date: 12/15/2006 End date: 06/30/2011 to request information from Principal Investigator.    Top of page 123I-mIBG - Open-Label, Multicenter, Phase 3 study Evaluating the Prognostic Usefulness of 123 I-mlBG Scintigraphy for identifying subjects with heart failure who will experience an adverse cardiac event   Principal Investigator: Sabahat Bokhari   Start date: 08/25/2005 End date: 12/31/2010 to request information from Principal Investigator.    Top of page ACT 1 - **STUDY MANAGER** ACT 1: Asymtomatic carotid stenosis, Stenting vs. endarterectory trial   Principal Investigator: William Gray   Start date: 10/13/2005 End date: 08/18/2009 to request information from Principal Investigator.    Top of page ADAPT DES - ADAPT DES Study: Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents   Principal Investigator: Giora Weisz   Start date: 06/04/2008 End date: 01/31/2015 to request information from Principal Investigator.    Top of page CHAMPION - CHAMPION: CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients.   Principal Investigator: Donna Mancini   Start date: 07/09/2008 End date: 05/01/2012 to request information from Principal Investigator.    Top of page CHAMPION - Clinical Trial Comparing Cangrelor to Clopidogrel in Subjects who Require Percutaneous Coronary Intervention   Principal Investigator: George Dangas   Start date: 04/24/2008 End date: 10/31/2010 to request information from Principal Investigator.    Top of page CHOICE-27236 - CHOICE Study - Carotid Stenting For High Surgical-Risk Patients; Evaluating Outcomes Through The Collection Of Clinical Evidence.   Principal Investigator: William Gray   Start date: 02/28/2008 End date: 08/31/2009 to request information from Principal Investigator.    Top of page COSTAR II - Cobalt Chromium Stent with Antiproliferative for Restenosis II Trial   Principal Investigator: Michael Collins   Website: unknown Start date: 06/08/2005 End date: 12/31/2009 to request information from Principal Investigator.    Top of page CREST - RO1 NS38384/Carotid Revascularization Endarterectomy vs. Stent Trial   Principal Investigator: William Gray   Start date: 10/10/2008 End date: 12/31/2011 to request information from Principal Investigator.    Top of page CUPID Trial - Calcium Up-Regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease   Principal Investigator: Donna Mancini   Start date: 05/04/2007 End date: 11/30/2012 to request information from Principal Investigator.    Top of page Carotid DVA   Principal Investigator: Issam D. Moussa   Start date: 01/27/2006 End date: 07/31/2009 to request information from Principal Investigator.    Top of page Complete SE Registry - **STUDY MANAGER** Complete SE Registry: Percutaneous interventional treatment of iliac artery lesions using the Medtronic Complete® Self-Expanding (SE) Iliac Stent.   Principal Investigator: William Gray   Start date: 04/15/2008 End date: 10/31/2010 to request information from Principal Investigator.    Top of page Cryo Cath - Cryocath Frezzor Cryo Ablation Catheter System   Principal Investigator: Hasan Garan   Start date: 02/07/2007 End date: 08/31/2009 to request information from Principal Investigator.    Top of page DETERMINE - Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation   Principal Investigator: Fredrick A Ehlert   Start date: 09/12/2008 End date: 01/07/2013 to request information from Principal Investigator.    Top of page Double-blind, prospective, randomized, placebo-controlled study to determine the tolerability, efficacy, safety, and dose range of intramyocardial injections of G-CSF mobilized Auto-CD34+ cells for reduction of angina episodes in pts with refractory   Principal Investigator: Warren Sherman   Start date: 08/14/2006 End date: 02/28/2011 to request information from Principal Investigator.    Top of page EMPIRE - **STUDY MANAGER** Embolic Protection with Reverse Flow Study of the Gore Neuro Protection System in Carotid Stenting of Subjects at High Risk for Carotid Endarterectomy   Principal Investigator: William Gray   Start date: 10/08/2007 End date: 03/31/2010 to request information from Principal Investigator.    Top of page ENDEAVOR 4 - **STUDY MANAGER** Randomized, controlled trial of the medtronic endeavor drug(ABT-578) eluting coronary stent system vs. the Taxus Paclitaxel-eluting coronary stent system in de novo native coronary lesions   Principal Investigator: Jeffrey W. Moses   Start date: 05/12/2005 End date: 11/30/2010 to request information from Principal Investigator.    Top of page ENDEAVOR SVS - **STUDY MANAGER** Endeavor SVS Registry: A Clinical Evaluation of the Medtronic Endeavor Zotarolimus-Eluting Coronary Stent System in the Treatment of Single De novo Lesions in Small Diameter Native Coronary Arteries.   Principal Investigator: Jeffrey W. Moses   Start date: 06/10/2008 End date: 10/31/2013 to request information from Principal Investigator.    Top of page EVEREST II - **STUDY MANAGER** A study of the Evalve Cardiovascular Valve repair system (CVRS) endovascular valve edge-to-edge repair study   Principal Investigator: William Gray   Start date: 03/21/2005 End date: 09/30/2009 to request information from Principal Investigator.    Top of page Lightlab M4 - **STUDY MANAGER** Evaluation of the M4 System for Imaging Stented Coronary Arteries-Device trial   Principal Investigator: Jeffrey W. Moses   Start date: 10/27/2008 End date: 04/30/2011 to request information from Principal Investigator.    Top of page MYOHEART - Myogenesis Heart Efficiency and Regeneration Trial   Principal Investigator: Warren Sherman   Start date: 07/11/2006 End date: 01/31/2012 to request information from Principal Investigator.    Top of page MediGuide Trial - **STUDY MANAGER** MediGuide Trial: Medical Positioning System (MPS) In Conjunction with Guided Measurement Catheter (GMC™) Feasibility Study in Clinical Routine.   Principal Investigator: Giora Weisz   Start date: 03/09/2008 End date: 09/30/2009 to request information from Principal Investigator.    Top of page Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of KW-3902 Injectable Emulsion on Heart Failure Signs and Symptoms, Diuresis, Renal Function, and Clinical Outcomes in Subjects Hospitalized with Worsening Renal Function   Principal Investigator: Paolo C. Colombo   Start date: 12/19/2007 End date: 07/31/2011 to request information from Principal Investigator.    Top of page Optivol Study - Correlation Between T Wave Alternans and Intrathoracic Impedance Measurements Using Optivol T Wave Alternans/Optivol Study.   Principal Investigator: Jose Dizon   Start date: 04/28/2007 End date: 10/31/2010 to request information from Principal Investigator.    Top of page PARTNER - **STUDY MANAGER** The PARTNER Trial: Placement of Aortic Transcatheter Valves Trial   Principal Investigator: Martin Leon   Start date: 05/29/2007 End date: 11/30/2009 to request information from Principal Investigator.    Top of page PROTECT AF - **STUDY MANAGER** Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation   Principal Investigator: William Gray   Start date: 01/31/2006 End date: 08/25/2009 to request information from Principal Investigator.    Top of page PROTECT-II - multicenter, randomized, double-blind, placebo-controlled study of the effects of KW-3902 Injectable Emulsion on heart failure signs and symptoms and renal function in subjects with acute heart failure signs and renal impairment who are hospi   Principal Investigator: Maryjane A. Farr   Start date: 02/14/2008 End date: 09/30/2010 to request information from Principal Investigator.    Top of page Pacing Chronotropic Incompetence - Cardiovascular and Neurohormonal Effects of Faster Atrial Pacing Rate For Six Hours in Patients With Congestive Heart Failure, Heart Rate <70 Beats per Minute and Fluid Overload.   Principal Investigator: Paolo C. Colombo   Start date: 06/16/2008 End date: 10/31/2009 to request information from Principal Investigator.    Top of page Perseus Trial - **STUDY MANAGER** Perseus Trial: A Prospective Evaluation in a Non-Randomized Trial of the Safety and Efficacy of the Use of the TAXUS[r] ElementTM Paclitaxel-Eluting Coronary Stent System for the Treatment   Principal Investigator: Jeffrey W. Moses   Start date: 01/28/2008 End date: 08/31/2013 to request information from Principal Investigator.    Top of page Perseus Workhorse Trial - **STUDY MANAGER** Perseus WorkhorseTrial: A Prospective Evaluation in a Non-Randomized of the Safety and Efficacy of the Use of the TAXUS (R) ElementTM Paclitaxel-Eluting Coronary Stent System for the Treatment   Principal Investigator: Jeffrey W. Moses   Start date: 01/28/2008 End date: 08/31/2013 to request information from Principal Investigator.    Top of page Power Disc-15 - Comparison of Safety and Inhalation Times of Ventavis (iloprost) Inhalation Solution Delivered by I-Neb Utilizing Power Disc-6 and Power Disc-15   Principal Investigator: Evelyn M Horn   Start date: 06/19/2007 End date: 12/31/2009 to request information from Principal Investigator.    Top of page Protect II (IMPELLA) - **STUDY MANAGER** PROTECT II: A Prospective, multi-center randomized controlled trial of the IMPELLA® RECOVER® LP 2.5 System versus Intra Aortic Balloon Pump (IABP) in Patients Undergoing Non-Emergent High Risk PCI   Principal Investigator: Michael Collins   Start date: 04/10/2008 End date: 10/31/2009 to request information from Principal Investigator.    Top of page RECORDAF - Registry on Cardiac Rhythm Disorders: An International, Observational, Prospective Survey Assessing the Control of Atrial Fibrillation.   Principal Investigator: James A. Reiffel   Start date: 01/16/2008 End date: 07/31/2009 to request information from Principal Investigator.    Top of page RED-HF Trial - Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects with Symptomatic Left Ventricular Systolic Dysfunction   Principal Investigator: Donna Mancini   Website: NETWORK Start date: 11/06/2006 End date: 05/31/2010 to request information from Principal Investigator.    Top of page REVERSE - Resynchronization reverses remodeling in systolic left ventricular dysfunction study, REVERSE   Principal Investigator: Evelyn M Horn   Start date: 02/03/2006 End date: 12/31/2011 to request information from Principal Investigator.    Top of page RIDE - The Impact of Cardiac Resynchronization Therapy Optimization on Indices of Mechanical Dyssynchrony during Exercise.   Principal Investigator: Fredrick A Ehlert   Start date: 04/22/2008 End date: 10/31/2010 to request information from Principal Investigator.    Top of page RIGHT - Rhythm ID going head to head Trial   Principal Investigator: Jose Dizon   Start date: 03/30/2006 End date: 09/30/2009 to request information from Principal Investigator.    Top of page Randomized Double blind placebo controlled parallel group trial to assess the efficacy and safety of Omacor for the prevention of recurrent symptomatic Atrial fibrillation   Principal Investigator: James A. Reiffel   Start date: 02/13/2007 End date: 08/31/2011 to request information from Principal Investigator.    Top of page Scoring Balloon Catheter - **STUDY MANAGER** AngioSculpt bifurcation trial: AngioSculpt scoring balloon catheter coronary bifurcation study protocol   Principal Investigator: Jeffrey W. Moses   Start date: 06/20/2008 End date: 10/31/2010 to request information from Principal Investigator.    Top of page T-wave Alternans and Ischemia - T-wave Alternans During Percutaneous Coronary Interventions.   Principal Investigator: Jose Dizon   Start date: 04/28/2008 End date: 10/31/2010 to request information from Principal Investigator.    Top of page THAOS - Global, Multi-Center, Longitudinal, Observational Survey of Patients with Documented Transthyretin (TTR) Mutations or Wild-Type TTR Amyloidosis.   Principal Investigator: Matthew Maurer   Start date: 12/04/2007 End date: 06/30/2018 to request information from Principal Investigator.    Top of page